Ifosfamide and etoposide in advanced‐stage, relapsed or refractory primary cutaneous T‐cell lymphomas. (13th July 2020) - Dangien, A.; Ram‐Wolff, C.; Brice, P.; Battistella, M.; Roelens, M.; Moins‐Teisserenc, H.; Peffault de Latour, R.; Mourah, S.; Bouaziz, J.‐D.; Lebbé, C.; Bagot, M.; de Masson, A.